Search
Searching Content by Natasha Pearman from Mishcon de Reya ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
Brexit Update – Continue To Prepare For A Hard Brexit
In the last edition of Inside Life Sciences, we reported on the draft EU withdrawal agreement that had been provisionally agreed between the UK and the EU27, including in relation to a proposed transition period ...
UK
31 May 2018
2
CJEU Rules On Roche/Novartis Agreement Restricting Off Label Use Of Avastin
On 23 January 2018, the European Court of Justice (CJEU) handed down its judgment in Case C-179/16 relating to an on-going saga concerning Hoffman-La Roche Ltd (Roche) ...
European Union
13 Apr 2018
3
Brexit Update
As the Brexit negotiations continue, the life sciences industry remains vocal. Central to its arguments has been: (1) the need for an agreement that will allow continued co-operation between the UK ...
European Union
13 Apr 2018
4
The Potential Implications Of A Brexit Customs Union On Pharma And Biotech Industries
This would represent a ‘soft Brexit', and would also mean the UK would not be free to strike its own trade deals with non-EU countries.
UK
2 Mar 2018
5
Patent Litigation And Remedies
In a landmark decision in the telecoms licensing battle between Unwired Planet and Huawei, Birss J has set what he considers to be a FRAND (Fair, Reasonable and Non-Discriminatory) ...
European Union
1 Feb 2018
6
Inside IP: The EU Approach To Standard Essential Patents
In April 2016, the European Commission identified three areas of the SEP licensing environment that needed improvement: (1) opaque information on SEP exposure ...
European Union
7 Dec 2017
7
Infliximab: Battle Of The Biosimilars
On 23 May, the CMA issued a statement of objections, which is a provisional finding that Merck Sharp & Dohme Limited (MSD) has breached UK competition law by abusing its dominant position.
UK
27 Nov 2017
Links to Result pages
 
1